Staff Directory

Filter By Surname
Filter By Position
Filter By Keyword
Filter By Cancer Type
Search
Professor Jack Cuzick
Director, Wolfson Institute of Preventive Medicine

I am the Director of Wolfson Institute of Preventive Medicine and also Head of Centre for Cancer Prevention. My current interests are in cancer epidemiology and clinical trials, with special interest in prevention and screening.

Professor Stephen Duffy
Professor of Cancer Screening

My research activities are concentrated on cancer screening and early diagnosis. There is potential for considerable saving of lives from cancer if it were diagnosed at an earlier stage.

Professor John F. Marshall
Professor of Tumour Biology

For over 25 years I have studied the biology of tumour invasion with a particular interest in the roles of the adhesion molecules expressed on the cell surface that mediate this process. Our group concentrates on the study of integrins that are the principal family of adhesion molecules that mediate interaction between cells and the extracellular matrix (ECM).

Professor Louise Jones
Professor of Breast Pathology

My research in breast cancer focuses on the progression of in-situ to invasive disease with the aims of identifying markers which can predict behaviour and novel therapeutic targets.

Dr Stéphanie Kermorgant
Reader in Cellular Oncology

We study the role of growth factor receptor signalling and intracellular trafficking (movement inside cells) in tumour growth and metastasis in the view of improving cancer therapy.

Dr Oliver M. Pearce
Lecturer

The focus of our research is the tumour microenvironment and we are particularly interested in understanding the composition and function of the tumour extracellular matrix in immunosuppression. Cancer types we focus on include ovarian and breast cancers.

Dr Barrie Peck
Lecturer

My lab aims to understand the alterations in metabolism that take place in cancer and investigate whether extrinsic factors, such as diet, influence cancer metabolism and disease trajectory. We then want to uncover whether these dependencies can be exploited therapeutically.

Professor Peter Schmid
Professor of Cancer Medicine

My research interests primarily focus on breast cancer, lung cancer and early drug development. I oversee clinical and translational research on immune checkpoint inhibitors and other immune strategies.

Dr Michael Allen

My research focuses on understanding the progression of early breast cancer (ductal carcinoma in situ – DCIS) to invasive disease and the role of the microenvironment in this process.

Dr Renato Brito Baleeiro

The primary focus of my research is to establish a platform for a neo-antigens-based vaccine for triple-negative breast cancer and pancreatic cancer.

Dr Katia Bouchekioua-Bouzaghou

My project aims to investigate how resistance mechanisms are acquired to a number of CDK4/6 inhibitors and to pinpoint new targets for therapy.

Dr Edward Carter

My research is focused on understanding the early stages of breast cancer by using normal human breast cells obtained through the Breast Cancer Now tissue bank as building blocks to recreate a human breast duct in the laboratory environment.

Dr Jesus Gomez Escudero

I am involved in some projects that are focused in the stroma components of a tumour, particularly the endothelial vessels, and its potential role in some key processes including chemotherapy or metastasis.

Dr Emanuela Gadaleta

We are updating the bioinformatics data management system, expanding the analytical modules and functionalities, developing purpose-built graphical pug-ins and designing the bioinformatics infrastructure to allow the querying and analysis of data returned from projects using BCNTB tissues.

Dr Peng Liu

I am interested in cancer prevention and immunotherapy using tumour-targeted replicating oncolytic viruses.

Dr Kate Moore

My research is focused on understanding how integrins help cancer cells invade and metastasise, as well as how we can use integrins as biomarkers of disease and therapeutic targets.

Dr Marie Nollet

Our group has shown that internalised c-Met traffics through endomembranes positive for LC3B and Beclin1. Furthermore, c-Met sustains signalling from Autophagy Related Endomembranes, ARE. We hypothesised therefore that the AREs supporting c-Met trafficking and signalling belong to a novel non-canonical pathway.

Dr Stefano Pirro

My research focuses on enhancing the freely-available Breast Cancer Now Tissue Bank bioinformatics portal (BCNTBbp) and its analytical layer to build a ‘multi-omic’ integration system for BCNTB returned data.

Dr Helen Ross-Adams

The aim of my work is to develop clinically-relevant biomarkers that could aid in earlier disease detection, predict treatment response, and inform clinical management of patients.

Dr Emily Saunderson

I am interested in understanding whether epigenetics can play a driving role in the transition from normal to transformed cells in the breast.

Dr Alice Shia

My main research focus is investigating the changes in circulating nucleic acids in blood samples from patients recruited in clinical trials. We are interested in how we can use non-invasive techniques to detect changes in tumour DNA and correlate that to patient outcome.

Dr Judith Simon

Our study aims to investigate the role of centrosome amplification on changing the tumour microenviroment using in vitro and in vivo models.

Dr Graeme Thorn

My research focuses on the bioinformatic analyses of DNA methylation of circulating tumour DNA and the use of DNA methylation as a biomarker for breast cancer prognosis.